Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications assessment inter intra rater reliability objective cough frequency patients chronic
… (PASS), risk evaluation and mitigation strategy (REMS) assessment studies, prospective and retrospective …
American Diabetes Association's 84th Scientific Sessions Share on: Friday, June 21 - Monday, June 24, 2024 Conference website Research coauthored by RTI Health Solutions experts will be presented at ADA's 84th Scientific Sessions. Preferences of people …
Martina Sluga-O'Callaghan Surveys and Observational Studies Lyon, France PhD, Genetics MD, Biology/Genetics University of Vienna, Vienna, Austria PD, Sales and Marketing Business University of Vienna, Vienna, Austria Dr. Sluga-O’Callaghan is Senior …
… the prevalence, incidence, and economic burden of various chronic and acute medical conditions. Mr. Davis also has …
… regulators, payers, providers, and patients—can make better decisions. …
… outcomes particularly in oncology studies, with numerous publications in this area. Her experience spans both the …
Nuria Saigi-Morgui Pharmacoepidemiology and Risk Management Barcelona, Spain PhD, Pharmacogenetics University of Lausanne, Lausanne, Switzerland MPH, School of Life Sciences Pompeu Fabra University, Barcelona, Spain PharmMSc, School of Pharmacy University …
RTI receives Cigna Healthy Workforce Designation ™ Share on: March 3, 2023 Image Cigna has selected nonprofit research institute RTI International, parent company of RTI Health Solutions, as a recipient of their silver level Healthy Workforce Designation …
Regulatory Priorities, Real-World Evidence, and the Safety and Effectiveness of COVID-19 Vaccines Share on: November 2, 2021 The ways COVID-19 vaccines are being administered have changed substantially in the last few months. Issues such as mixing and …
… of life with efficacy outcomes in the VISION study of patients with metastatic castration-resistant prostate … checkpoint inhibitor and subsequent surgical resection in patients with BRAF V600–mutated stage III/IV melanoma. Weber …